F, C. S., M, L., A, M., K, C., & S, E. B. (2024). Effect of glucocorticoids for the management of immune-related adverse events on outcome in melanoma patients treated with immunotherapy-a retrospective and biomarker study. Immuno-oncology technology, 22, 100713. https://doi.org/10.1016/j.iotech.2024.100713
Chicago Style (17th ed.) CitationF, Costa Svedman, Liapi M, Månsson-Broberg A, Chatzidionysiou K, and Egyhazi Brage S. "Effect of Glucocorticoids for the Management of Immune-related Adverse Events on Outcome in Melanoma Patients Treated with Immunotherapy-a Retrospective and Biomarker Study." Immuno-oncology Technology 22 (2024): 100713. https://doi.org/10.1016/j.iotech.2024.100713.
MLA (9th ed.) CitationF, Costa Svedman, et al. "Effect of Glucocorticoids for the Management of Immune-related Adverse Events on Outcome in Melanoma Patients Treated with Immunotherapy-a Retrospective and Biomarker Study." Immuno-oncology Technology, vol. 22, 2024, p. 100713, https://doi.org/10.1016/j.iotech.2024.100713.
